Impaired immune responses following spinal cord injury lead to reduced ability to control viral infection

Experimental Neurology

Volumn 226, Issue 1, 2010, Pages 242-253

  Held, Katherine S ^a   Steward, Oswald ^a,b   Blanc, Caroline ^a   Lane, Thomas E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autonomic; Immunity; Immunosuppression; Infection; Spinal cord injury; Spleen; Virus

Indexed keywords

GAMMA INTERFERON; VIRUS RNA;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL COUNT; CELL INFILTRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CRUSH TRAUMA; CYTOKINE PRODUCTION; FEMALE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFECTION SENSITIVITY; INNATE IMMUNITY; LAMINECTOMY; LYMPHOCYTE PROLIFERATION; MORTALITY; MOUSE; MURINE HEPATITIS CORONAVIRUS; NERVE INJURY; NONHUMAN; PRIORITY JOURNAL; RNA VIRUS INFECTION; SPINAL CORD INJURY; VIRUS IMMUNITY; VIRUS REPLICATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL PROLIFERATION; CORONAVIRUS INFECTION; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOLOGY; MACROPHAGE ACTIVATION; METABOLISM; MONOCYTE; PATHOLOGY; PHYSIOLOGY; SPLEEN; T LYMPHOCYTE; VIROLOGY; VIRUS INFECTION; VIRUS LOAD;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CORONAVIRUS INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; INTERFERON-GAMMA; MACROPHAGE ACTIVATION; MICE; MICE, INBRED C57BL; MONOCYTES; MURINE HEPATITIS VIRUS; RNA, VIRAL; SPINAL CORD INJURIES; SPLEEN; T-LYMPHOCYTES; VIRAL LOAD; VIRUS DISEASES;

EID: 77957761011     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2010.08.036     Document Type: Article

References (42)

1. Bellinger D.L., Felten S.Y., Lorton D., Feltenm D.L. Innervation of lymphoid organs and neurotransmitter-lymphocyte interaction. Immunol. Nerv. Syst. 1979, 226-329.
2. Bergmann C.C., Yao Q., Lin M., Stohlman S.A. The JHM strain of mouse hepatitis virus induces a spike protein-specific Db-restricted cytotoxic T cell response. J. Gen. Virol. 1996, 77(Pt 2):315-325.
3. Campagnolo D.I., Bartlett J.A., Keller S.E., Sanchez W., Oza R. Impaired phagocytosis of Staphylococcus aureus in complete tetraplegics. Am. J. Phys. Med. Rehabil. 1997, 76:276-280.
4. Campagnolo D.I., Dixon D., Schwartz J., Bartlett J.A., Keller S.E. Altered innate immunity following spinal cord injury. Spinal Cord 2008, 46:477-481.
5. Cano G., Sved A.F., Rinaman L., Rabin B.S., Card J.P. Characterization of the central nervous system innervation of the rat spleen using viral transneuronal tracing. J. Comp. Neurol. 2001, 439:1-18.
6. Cardenas D.D., Hoffman J.M., Kirshblum S., McKinley W. Etiology and incidence of rehospitalization after traumatic spinal cord injury: a multicenter analysis. Arch. Phys. Med. Rehabil. 2004, 85:1757-1763.
7. Castro R.F., Perlman S. CD8+ T-cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity. J. Virol. 1995, 69:8127-8131.
8. Cruse J.M., Keith J.C., Bryant M.L., Lewis R.E. Immune system-neuroendocrine dysregulation in spinal cord injury. Immunol. Res. 1996, 15:306-314.
9. Cruse J.M., Lewis R.E., Dilioglou S., Roe D.L., Wallace W.F., Chen R.S. Review of immune function, healing of pressure ulcers, and nutritional status in patients with spinal cord injury. J. Spinal Cord Med. 2000, 23:129-135.
10. Cruse J.M., Lewis R.E., Roe D.L., Dilioglou S., Blaine M.C., Wallace W.F., Chen R.S. Facilitation of immune function, healing of pressure ulcers, and nutritional status in spinal cord injury patients. Exp. Mol. Pathol. 2000, 68:38-54.
11. Downing J.E., Miyan J.A. Neural immunoregulation: emerging roles for nerves in immune homeostasis and disease. Immunol. Today 2000, 21:281-289.
12. Eriksson K.K., Cervantes-Barragan L., Ludewig B., Thiel V. Mouse hepatitis virus liver pathology is dependent on ADP-ribose-1″-phosphatase, a viral function conserved in the alpha-like supergroup. J. Virol. 2008, 82:12325-12334.
13. Held K.S., Glass W.G., Orlovsky Y.I., Shamberger K.A., Petley T.D., Branigan P.J., Carton J.M., Beck H.S., Cunningham M.R., Benson J.M., Lane T.E. Generation of a protective T-cell response following coronavirus infection of the central nervous system is not dependent on IL-12/23 signaling. Viral Immunol. 2008, 21:173-188.
14. Hirano N., Murakami T., Fujiwara K., Matsumoto M. Utility of mouse cell line DBT for propagation and assay of mouse hepatitis virus. Jpn J. Exp. Med. 1978, 48:71-75.
15. Ibarra A., Jimenez A., Cortes C., Correa D. Influence of the intensity, level and phase of spinal cord injury on the proliferation of T cells and T-cell-dependent antibody reactions in rats. Spinal Cord 2007, 45:380-386.
16. Iversen P.O., Hjeltnes N., Holm B., Flatebo T., Strom-Gundersen I., Ronning W., Stanghelle J., Benestad H.B. Depressed immunity and impaired proliferation of hematopoietic progenitor cells in patients with complete spinal cord injury. Blood 2000, 96:2081-2083.
17. Klehmet J., Harms H., Richter M., Prass K., Volk H.D., Dirnagl U., Meisel A., Meisel C. Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience 2009, 158:1184-1193.
18. Kruszewska B., Felten S.Y., Moynihan J.A. Alterations in cytokine and antibody production following chemical sympathectomy in two strains of mice. J. Immunol. 1995, 155:4613-4620.
19. Lane T.E., Liu M.T., Chen B.P., Asensio V.C., Samawi R.M., Paoletti A.D., Campbell I.L., Kunkel S.L., Fox H.S., Buchmeier M.J. A central role for CD4(+) T cells and RANTES in virus-induced central nervous system inflammation and demyelination. J. Virol. 2000, 74:1415-1424.
20. Lorton D., Lubahn C., Lindquist C.A., Schaller J., Washington C., Bellinger D.L. Changes in the density and distribution of sympathetic nerves in spleens from Lewis rats with adjuvant-induced arthritis suggest that an injury and sprouting response occurs. J. Comp. Neurol. 2005, 489:260-273.
21. Lucin K.M., Sanders V.M., Jones T.B., Malarkey W.B., Popovich P.G. Impaired antibody synthesis after spinal cord injury is level dependent and is due to sympathetic nervous system dysregulation. Exp. Neurol. 2007, 207:75-84.
22. Lucin K.M., Sanders V.M., Popovich P.G. Stress hormones collaborate to induce lymphocyte apoptosis after high level spinal cord injury. J. Neurochem. 2009, 110:1409-1421.
23. MacNeil B.j., Nance D.M. Skin inflammation and immunity after spinal cord injury. Neuroimmune Biology, New Foundation of Biology 2001, 455-469. Elsevier Science B.V., Amsterdam, The Netherlands. I. Berczi, A. Szentivanyi (Eds.).
24. Matthews A.E., Weiss S.R., Shlomchik M.J., Hannum L.G., Gombold J.L., Paterson Y. Antibody is required for clearance of infectious murine hepatitis virus A59 from the central nervous system, but not the liver. J. Immunol. 2001, 167:5254-5263.
25. Meisel C., Schwab J.M., Prass K., Meisel A., Dirnagl U. Central nervous system injury-induced immune deficiency syndrome. Nat. Rev. Neurosci. 2005, 6:775-786.
26. Mignini F., Streccioni V., Amenta F. Autonomic innervation of immune organs and neuroimmune modulation. Auton. Autacoid Pharmacol. 2003, 23:1-25.
27. Muse M., Kane J.A., Carr D.J., Farber J.M., Lane T.E. Insertion of the CXC chemokine ligand 9 (CXCL9) into the mouse hepatitis virus genome results in protection from viral-induced encephalitis and hepatitis. Virology 2008, 382:132-144.
28. Navas S., Seo S.H., Chua M.M., Das Sarma J., Lavi E., Hingley S.T., Weiss S.R. Murine coronavirus spike protein determines the ability of the virus to replicate in the liver and cause hepatitis. J. Virol. 2001, 75:2452-2457.
29. Pan J., Ju D., Wang Q., Zhang M., Xia D., Zhang L., Yu H., Cao X. Dexamethasone inhibits the antigen presentation of dendritic cells in MHC class II pathway. Immunol. Lett. 2001, 76:153-161.
30. Riegger T., Conrad S., Liu K., Schluesener H.J., Adibzahdeh M., Schwab J.M. Spinal cord injury-induced immune depression syndrome (SCI-IDS). Eur. J. Neurosci. 2007, 25:1743-1747.
31. Sanders V.M., Straub R.H. Norepinephrine, the beta-adrenergic receptor, and immunity. Brain Behav. Immun. 2002, 16:290-332.
32. Sanders V.M., Baker R.A., Ramer-Quinn D.S., Kasprowicz D.J., Fuchs B.A., Street N.E. Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J. Immunol. 1997, 158:4200-4210.
33. Schijns V.E., Haagmans B.L., Wierda C.M., Kruithof B., Heijnen I.A., Alber G., Horzinek M.C. Mice lacking IL-12 develop polarized Th1 cells during viral infection. J. Immunol. 1998, 160:3958-3964.
34. Schmid F.A., Pena R.C., Robinson W., Tarnowski G.S. Toxicity of intraperitoneal injections of 7, 12-dimethylbenz[a]anthracene in inbred mice. Cancer Res. 1967, 27:558-562.
35. Soden R.J., Walsh J., Middleton J.W., Craven M.L., Rutkowski S.B., Yeo J.D. Causes of death after spinal cord injury. Spinal Cord 2000, 38:604-610.
36. Stiles L.N., Hardison J.L., Schaumburg C.S., Whitman L.M., Lane T.E. T cell antiviral effector function is not dependent on CXCL10 following murine coronavirus infection. J. Immunol. 2006, 177:8372-8380.
37. Teasell R.W., Arnold J.M., Krassioukov A., Delaney G.A. Cardiovascular consequences of loss of supraspinal control of the sympathetic nervous system after spinal cord injury. Arch. Phys. Med. Rehabil. 2000, 81:506-516.
38. Trifilo M.J., Montalto-Morrison C., Stiles L.N., Hurst K.R., Hardison J.L., Manning J.E., Masters P.S., Lane T.E. CXC chemokine ligand 10 controls viral infection in the central nervous system: evidence for a role in innate immune response through recruitment and activation of natural killer cells. J. Virol. 2004, 78:585-594.
39. Walsh K.B., Edwards R.A., Romero K.M., Kotlajich M.V., Stohlman S.A., Lane T.E. Expression of CXC chemokine ligand 10 from the mouse hepatitis virus genome results in protection from viral-induced neurological and liver disease. J. Immunol. 2007, 179:1155-1165.
40. Walsh K.B., Lodoen M.B., Edwards R.A., Lanier L.L., Lane T.E. Evidence for differential roles for NKG2D receptor signaling in innate host defense against coronavirus-induced neurological and liver disease. J. Virol. 2008, 82:3021-3030.
41. Wijburg O.L., Heemskerk M.H., Sanders A., Boog C.J., Van Rooijen N. Role of virus-specific CD4+ cytotoxic T cells in recovery from mouse hepatitis virus infection. Immunology 1996, 87:34-41.
42. Xue S., Jaszewski A., Perlman S. Identification of a CD4+ T cell epitope within the M protein of a neurotropic coronavirus. Virology 1995, 208:173-179.